
Tesamorelin
25.000,00 EGP
Clinically proven visceral abdominal fat reduction. Growth hormone-releasing factor analogue.
Description
What It Is
Tesamorelin is a growth hormone-releasing factor analogue specifically targeting visceral abdominal fat. It is the only peptide clinically approved for abdominal fat reduction.
Best For
- Stubborn visceral abdominal fat
- Metabolic syndrome and insulin resistance
- Body recomposition with abdominal focus
Key Benefits
- Clinically proven reduction in visceral abdominal fat
- Improves body composition and waist circumference
- Supports GH levels without suppressing natural production
Dosage Protocol
Beginner: 1 mg daily
Common: 2 mg daily
Advanced: 2 mg daily with cycling protocol
Included With Every Order
โ Reconstitution solution, reconstitution syringe, and administration syringes included.
